Femistina
Natural health product licensed in Canada
- Licence holder
- Claride Pharma srl
- NPN or DIN-HM
- 80096803
- Status
- Active licence
- Licence date
- 23 January 2020
- Revision date
- 16 October 2020
- Form
- Kit
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-mannose Source : D-Mannose | 420 mg | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 1,155 mg Potency : 10 % Arbutin | 385 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Stéarate de magnésium, Gélatine, Gelatin, Oxyde de Fer Jaune, Dioxyde de silicium, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps prevent recurrent urinary tract infections. Provides natural help in urinary tract infection recurrences.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80096803
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging